Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2014 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Allergy and Infectious Diseases (NIAID) )
ClinicalTrials.gov Identifier:
NCT00001645
First received: November 3, 1999
Last updated: October 4, 2014
Last verified: September 2014

November 3, 1999
October 4, 2014
March 1997
Not Provided
  • To evaluate, treat and follow patients with parasitic infections not covered by existing LPD/NIAID protocols [ Time Frame: Continuous ] [ Designated as safety issue: No ]
  • To screen patients with suspected parasitic infections for enrollment on other LPD/NIAID protocols [ Time Frame: Continuous ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT00001645 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
Evaluation, Treatment, and Monitoring of Patients With Known or Suspected Parasitic Infection

The purpose of this study is to evaluate, treat and follow patients with parasitic infections.

People with a known or suspected parasitic infection who are at least 1 year old may be enrolled. This study does not involve any experimental treatments.

Participants will have a physical examination and laboratory tests on blood, stool, or urine. Blood samples may be collected at regular intervals, but no more than 450 ml (15 ounces) of blood will be drawn from adults, and no more than 7 ml (1-1/2 teaspoons) per kg (2.2 pounds) of body weight from children, in any 6-week period. Other tests may include x-rays, electrocardiogram (EKG), or tissue biopsy (surgical removal of a small tissue sample), depending on the individual s condition.

Patients may be offered treatment or may be referred to another study that is more appropriate for the problem. Any treatment provided in this study will be according to standard medical practice for the patient s specific medical problem. Patients responses to treatment will be evaluated at regularly scheduled clinic visits. The length of time between visits and the total duration of the study for a given individual will be determined by the study doctor, based on that person s medical condition.

This study is designed as a prospective study to evaluate and treat patients with parasitic infection. Patients with known or suspected parasitic infection will be enrolled and will be evaluated for the presence of a parasitic infection. Minimal studies scheduled for each visit will include a medical history, physical examination, routine laboratory tests and specialized diagnostic procedures for possible parasitic infections. Treatment plans will be individualized for each patient's particular condition, and the number and length of additional visits and diagnostic evaluations will vary accordingly. Specific treatment regimens will be in accordance with standard medical practice.

Observational
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
Parasitic Disease
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
500
Not Provided
Not Provided
  • INCLUSION CRITERIA:

Age 1 or over.

Access to a primary medical care provider outside of the NIH.

Ability to give written informed consent (for adults) and parental consent (for those under 18).

Clinical evidence suggestive of a parasitic infection.

EXCLUSION CRITERIA:

Less than 1 year of age.

No evidence suggestive of a parasitic infection.

Both
1 Year and older
No
Contact: Tamika S Magee, R.N. (301) 443-5458 mageets@mail.nih.gov
Contact: Thomas B Nutman, M.D. (301) 496-5398 tnutman@mail.nih.gov
United States
 
NCT00001645
970096, 97-I-0096
Not Provided
National Institutes of Health Clinical Center (CC) ( National Institute of Allergy and Infectious Diseases (NIAID) )
National Institute of Allergy and Infectious Diseases (NIAID)
Not Provided
Principal Investigator: Thomas B Nutman, M.D. National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health Clinical Center (CC)
September 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP